← Back to Search

Physical Activity Program Choices for Cancer Survivors

N/A
Waitlist Available
Led By Jamie M Faro, PhD
Research Sponsored by University of Massachusetts, Worcester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3- and 6-months
Awards & highlights

Study Summary

This trial aims to reduce deaths from cardiovascular disease in cancer survivors. Physical activity can help, and ActivityChoice will support survivors so they can make the best decisions for their health.

Who is the study for?
This trial is for cancer survivors who are at least 18 years old, speak English, and have a history of cardiovascular disease or lead a sedentary lifestyle. It's designed to help them become more active through different types of physical activity programs.Check my eligibility
What is being tested?
ActivityChoice is testing how well two referral methods work to get cancer survivors into physical activity programs. One method gives patients extra support in choosing an activity program, while the other offers standard advice.See study design
What are the potential side effects?
Since this trial involves physical activity programs rather than medication, side effects may include typical exercise-related issues such as muscle soreness or fatigue but will vary based on individual health conditions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3- and 6-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3- and 6-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of patients referred as obtained by the electronic referral system and electronic health record
Secondary outcome measures
Clinic/Clinician fidelity of delivering patient decision aids
Patient Autonomous Regulation
Patient Engagement
+6 more
Other outcome measures
Clinician, Patient, Leadership, and External Partner Acceptability

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Enhanced ReferralExperimental Treatment1 Intervention
Provider education/training on referral process Patient education material on physical activity benefits Patient decision aid on physical activity program choices Electronic referral to program of patient's choice Fitbit Activity Monitor
Group II: Standard ReferralActive Control1 Intervention
Provider education/training on referral process Patient education material on physical activity benefits Paper referral to LIVESTRONG at the YMCA Fitbit Activity Monitor

Find a Location

Who is running the clinical trial?

University of Massachusetts, WorcesterLead Sponsor
342 Previous Clinical Trials
976,496 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,696 Previous Clinical Trials
6,952,465 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,834 Previous Clinical Trials
47,310,521 Total Patients Enrolled

Media Library

Enhanced Referral Clinical Trial Eligibility Overview. Trial Name: NCT05870176 — N/A
Cardiovascular Disease Research Study Groups: Standard Referral, Enhanced Referral
Cardiovascular Disease Clinical Trial 2023: Enhanced Referral Highlights & Side Effects. Trial Name: NCT05870176 — N/A
Enhanced Referral 2023 Treatment Timeline for Medical Study. Trial Name: NCT05870176 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria must be met in order to participate in this clinical experiment?

"Prospective enrollees must possess a sedentary lifestyle and have an age between 18 to 110. This medical trial is seeking a total of 114 individuals."

Answered by AI

Does this clinical research accept individuals aged seventy and older?

"The requirements for enrollment in this study specify that participants must be at least 18 and no older than 110 years of age."

Answered by AI

Is this study currently recruiting participants?

"According to clinicaltrials.gov, the recruitment for this trial has closed as of May 22nd 2023; however, there are still 1,057 other trials currently seeking patients."

Answered by AI
~76 spots leftby Aug 2026